Shorter TB treatment for less severe lung TB
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether a shorter, rifampicin-based treatment works well for people with less severe TB in the lungs. If you have limited TB that is sensitive to rifampicin, you might be able to take medicine for a shorter time than usual.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older
- You have TB in your lungs (confirmed by a test like GeneXpert that shows the bacteria are sensitive to rifampicin)
- Your TB is not severe—the bacteria level in your sputum is medium or low
- You have not already taken more than 7 days of TB medication for this episode
- You are well enough to be treated at home (not needing hospitalization)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether you can take a shorter course of standard treatment for drug-sensitive pulmonary (lung) tuberculosis by using a higher dose of rifampicin. It may help some people finish treatment sooner, while doctors track how well the infection clears.
This trial tests a shorter treatment for TB that is resistant to the drug rifampicin but still sensitive to isoniazid. It may help people finish treatment sooner and with fewer side effects.
This trial tests if a shorter treatment course works as well as the standard one for people whose chest X-rays suggest TB but whose sputum tests are negative. It aims to make treatment easier for patients.
This trial studies whether a rifapentine-based TB regimen can work just as well while shortening treatment time. It’s for people with rifampicin-sensitive, smear-positive lung tuberculosis.
This study is testing whether a shorter course of TB medicine works just as well as the standard longer treatment for children with drug-susceptible tuberculosis. It aims to make treatment easier for families.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
Hear when a new Pulmonary TB trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.